HL7 Australia Implementation Guide: home
This page is part of the RCPA Cancer Protocols IG (v0.1.0: Release 1 Draft) based on FHIR R3. . For a full list of available versions, see the Directory of published versions 
The set of values for recording clinical manifestation of an adverse reaction.
A set of values used to refer to medicines and other therapeutic goods.
The set of values for the agent or substance causing the adverse reaction experienced by the subject of care.
Indicates whether a new primary cancer or a regional recurrence or distant metastases.
This is the code indicates the type of course.
These codes are the relevant colorectal cancer associated coexistent pathological abnormalities.
This is the code indicates the maximum degree of local invasion into or through the bowel wall.
For rectal resections this field indicates the intactness of the mesorectum.
Indicates whether a colorectal tumour specimen was involved or not involved.
This is the code indicates the type of operation for the colorectal cancer.
Any involvement of the peritoneum should be recorded.
For rectal tumours this indicates the options for the relationship to anterior peritoneal reflection.
This code indicates the location of the colorectal tumour.
Lists the options for Colorectal cancer tumour stage grouping
Lists the options for Colorectal cancer tumour stage M
Lists the options for Colorectal cancer tumour stage N
Lists the options for Colorectal cancer tumour stage T
This code indicates the type of the colorectal tumour. A single selection value list from WHO Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System (2010).
This is the code has the options of Distal or Proximal.
Indicates the presence or absence of dysplasia
This is the code has the options of Not identified or present.
This is the code has the options of Focal or Non-focal.
This is the code indicates the primary Gleeson grade.
This is the code indicates the secondary Gleeson grade.
This is the code indicates the tertiary Gleeson grade.
This is the code has the options of High, Low and Ultralow.
Indicates the histological grade of the tumour
This is the code has the options of Not identified or present.
Indicates whether the margin status was involved, not involved or indeterminate.
Indicates whether a specimen was involved, not involved or not applicable.
Indicates whether a specimen was involved or not involved.
The codes for laterality.
These are the options for the margin status.
MSI options.
Mutated or wildtype gene mutation options.
Lists the options for recording the a new primary cancer or a residual cancer, if known.
This is the code indicates the nodule location by quadrant.
Indicates if there are any other nodules present.
This is the code has the options of Not identified, Present or Indeterminate.
This is the code has the options of Not identified, present and present and extensive.
This is the code has the options of Not identified or present.
Indicates the options for indicating the type(s) of perforation.
This is the code has the options of Not identified, present and present and extensive.
This is the code indicates presence or abscence.
This is the code indicates presence or abscence and not stated.
This is the code indicates presence or abscence.
Options for bladder enck involvement.
These are the options for the extent of the extraprostatic extension.
This is the code indicates the extraprostatic extension.
Indicates the options for type of margin positivity.
This is the code indicates the nodule location by plane.
Options for presence (partially or completeley resected) or absence of seminal vesicles.
Options for presence (partially or completeley resected) or absence of seminal vesicles.
These are the options for the radical prostatectomy locations.
The options for radical prostatectomy tumour stage M.
The options for radical prostatectomy tumour stage N.
The options for radical prostatectomy tumour stage T.
Indicates the radical prostatectomy tumour type.
Indicates whether a specimen was Received or Not received.
Lists the options for residual tumour status
The response of the tumour to neoadjuvant treatment must be recorded.
This is the code has the options of Not identified, present and present and extensive.
Stain type options.
Provides the results options of stable, unstable or not tested.
This is the code has the options of Yes, No or Not stated.
This is the code has the options of Yes or No.
© ADHA/HL7 Australia 2014+. Based on FHIR (v) generated on .
|
Propose a change 